NCT05544864View on ClinicalTrials.gov

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

NARecruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Coronary Artery DiseaseRestenoses, Coronary
Interventions
DEVICE

Drug eluting stent (DES)

DES-implantation with an everolimus-eluting stent (Xience, Abbott Vascular)

DEVICE

Drug coated ballloon (DCB)

DCB angioplasty with any commercially available drug-coated balloon

Trial Locations (5)

28006

RECRUITING

Hospital Universitario de La Princesa Madrid, Madrid

45138

RECRUITING

Elisabeth-Krankenhaus Essen GmbH, Essen

80636

RECRUITING

Deutsches Herzzentrum München, Munich

D-60596

RECRUITING

Universitätsklinikum Frankfurt, Frankfurt am Main

D-20246

RECRUITING

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

EvidentIQ Germany GmbH

UNKNOWN

collaborator

Abbott

INDUSTRY

collaborator

Technical University of Munich

OTHER

lead

Deutsches Herzzentrum Muenchen

OTHER